Skip to main content

Advertisement

Table 1 Characteristics of Studies Included in Meta-analysis

From: How to select patients and timing for rectal indomethacin to prevent post-ERCP pancreatitis: a systematic review and meta-analysis

Study Year Location Indomethacin (n) Placebo (n) Number of PEPs (n) Intervention Definition of PEP
Montaño Loza et al. 2007 Mexico 75 75 16 100 mg indomethacin 2 h before ERCP Pain, Amylase > 3 times
Sotoudehmane sh et al. 2007 Iran-Single centre 245 245 22 100 mg indomethacin immediately before ERCP Pain, Amylase > 3 times admission
Elmunzer et al. 2012 US-Multicentre 295 307 79 two 50-mg indomethacin after ERCP Pain, Amylase > 3 times admission > 2 nigh
döbrönte et al. 2014 Hungary-Multicentre 347 318 42 100 mg indomethacin 10–15 min before ERCP Pain, Amylase > 3 times a prolognation of admission, CT/MRI
Andrade-Dávila et al. 2015 Mexico 82 84 21 100 mg indomenthacin after ERCP Pain, Amylase > 3 times admission > 2 nigh
Patai et al. 2015 USA-Single centre 270 296 55 100 mg indomethacin within 1 before ERCP Pain, Amylase > 3 times
Levenick et al. 2016 USA-Single centre 223 226 27 two 50-mg indomethacin during ERCP Pain, Amylase > 3 times admission > 2 nigh